Concepedia

C. Weyer

CW

Statistics

Publications

30

Citations

4.9K

H-Index

28

Active since

1993

Affiliations

National Institutes of Health(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

Heinrich Heine University Düsseldorf

Novo Nordisk (Germany)

Amplyx Pharmaceuticals (United States)

C. Weyer is an author at National Institutes of Health specializing in endocrinology, diabetes mellitus, and medicine.

Publications per year

1993–2009

30

Publications

30

Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia

C. Weyer · The Journal of Clinical Endocrinology & Metabolism · 2001 · 853 citations

Medicine, Biochemistry, Endocrinology +12

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance

C. Weyer, James E. Foley, Clifton Bogardus et al. · Diabetologia · 2000 · 791 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Robert E. Ratner, Richard A. Dickey, Mark Fineman et al. · Diabetic Medicine · 2004 · 307 citations

Medicine, Endocrinology, Pharmacotherapy +17

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

C. Weyer, Robert L. Hanson, P. Antonio Tataranni et al. · Diabetes · 2000 · 305 citations · Full text

Medicine, Endocrinology, Diabetology +13

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

C. Weyer, Clifton Bogardus, Richard E. Pratley · Diabetes · 1999 · 293 citations

Medicine, Endocrinology, Physiology +15

1–5 of 30